Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02691572Completed
Randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain, sponsored by Mansoura University. Primary endpoint: Cumulative Fentanyl Dose at 24 hours. Started Feb 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02691572.